Route 92 Medical’s Monopoint® Operating Platform Shows 82% First Pass Effect in Independent Study
25 juil. 2022 07h00 HE
|
Route 92 Medical, Inc.
SAN MATEO, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a private medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention,...
Route 92 Medical® Announces Publication of Initial SUMMIT NZ Clinical Trial Results Demonstrating 80% First Pass Effect with the 088 Monopoint® Operating Platform
06 juin 2022 16h30 HE
|
Route 92 Medical, Inc.
SAN MATEO, Calif., June 06, 2022 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a private medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention,...
Route 92 Medical® Announces Receipt of 40th Patent for its Monopoint® Operating Platform Designed for Neurovascular Intervention
26 avr. 2022 15h00 HE
|
Route 92 Medical, Inc.
SAN MATEO, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular...
Route 92 Medical® Announces First Patient Enrollment in the SUMMIT MAX Pivotal Clinical Trial for the Monopoint® Reperfusion System
08 févr. 2022 08h00 HE
|
Route 92 Medical, Inc.
SAN MATEO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a private medical technology company dedicated to becoming the performance leader in acute ischemic stroke intervention,...
Route 92 Medical Raises $111 Million in Combined Series E and Debt Financing
14 déc. 2021 16h10 HE
|
Route 92 Medical, Inc.
SAN MATEO, Calif., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a private medical technology company dedicated to becoming the performance leader in stroke intervention, today announced...
Route 92 Medical Announces Appointment of Blaise W. Baxter, M.D., as Chief Clinical Officer
30 nov. 2021 16h10 HE
|
Route 92 Medical, Inc.
SAN MATEO, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a private medical technology company dedicated to becoming the performance leader in stroke intervention, today announced...